Skip to main content
. 2019 Feb 8;55(2):42. doi: 10.3390/medicina55020042

Figure 1.

Figure 1

Chemical structures of the main tyrosine kinase inhibitors currently under investigation for targeted treatment of cholangiocarcinoma.